RPS6KB1 and ovarian cancer: Our results suggest that targeting p70S6K could provide the best approach to inhibiting the progression of ovarian cancer in its initial stage, including ovarian carcinomas that may be localized in the ovary but have malignant ascites or positive peritoneal washings, and also that have not been completely removed during surgery at the microscopic level.